Scarica l'app Stockscreener
33.93
2.15%
-0.7775
Precedente Chiudi:
$34.71
Aprire:
$34.63
Volume 24 ore:
614.36K
Relative Volume:
0.44
Capitalizzazione di mercato:
$1.90B
Reddito:
$249.12M
Utile/perdita netta:
$-90.19M
Rapporto P/E:
-19.96
EPS:
-1.7
Flusso di cassa netto:
$-88.21M
1 W Prestazione:
+7.96%
1M Prestazione:
-5.29%
6M Prestazione:
-40.38%
1 anno Prestazione:
-61.20%
Intervallo 1D:
$33.68
$34.67
Intervallo di 1 settimana:
$30.60
$35.40
Portata 52W:
$27.80
$88.00
Procept Biorobotics Corp Stock (PRCT) Company Profile
Nome
Procept Biorobotics Corp
Settore
Industria
Telefono
(650) 232-9832
Indirizzo
150 BAYTECH DRIVE, SAN JOSE
Confronta PRCT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
33.94 | 1.94B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
127.01 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.61 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.23 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.50 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.56 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-12 | Iniziato | UBS | Buy |
| 2025-12-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-09-02 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-07-09 | Iniziato | Stephens | Overweight |
| 2025-07-07 | Iniziato | Oppenheimer | Perform |
| 2024-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2024-11-14 | Iniziato | Jefferies | Hold |
| 2023-08-11 | Iniziato | Piper Sandler | Overweight |
| 2023-05-31 | Iniziato | William Blair | Outperform |
| 2022-10-31 | Iniziato | BTIG Research | Neutral |
| 2022-10-25 | Iniziato | Truist | Buy |
| 2022-09-02 | Iniziato | Wells Fargo | Overweight |
| 2022-07-15 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | Iniziato | B. Riley Securities | Buy |
| 2021-10-11 | Iniziato | BofA Securities | Buy |
| 2021-10-11 | Iniziato | Cowen | Outperform |
| 2021-10-11 | Iniziato | Goldman | Neutral |
| 2021-10-11 | Iniziato | Guggenheim | Buy |
| 2021-10-11 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Procept Biorobotics Corp Borsa (PRCT) Ultime notizie
PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: A 53% Potential Upside in the Surgical Robotics Arena - DirectorsTalk Interviews
How Investors Are Reacting To PROCEPT BioRobotics (PRCT) UBS Coverage Initiation And 2027 Profitability Outlook - simplywall.st
What Wall Street predicts for PROCEPT BioRobotics Corporation stock priceConsumer Goods Stocks & Free Record-Breaking Gains - Bollywood Helpline
Promising Growth Forecasts Leading to Analysts' Optimism for Procept Biorobotics (PRCT) - Finviz
Promising growth forecasts leading to analysts’ optimism for Procept Biorobotics (PRCT) - MSN
Promising Growth Forecasts Leading to Analysts’ Optimism for Procept Biorobotics (PRCT) - Yahoo Finance
15 Most Promising Mid-Cap Healthcare Stocks Under $50 - Insider Monkey
Aug EndMonth: What Wall Street predicts for PROCEPT BioRobotics Corporation stock priceJuly 2025 Gainers & AI Driven Stock Movement Reports - Улправда
Transcript : PROCEPT BioRobotics Corporation Presents at Piper Sandler 37th Annual Healthcare Conference, Dec-02-2025 08 - marketscreener.com
Will PROCEPT BioRobotics Corporation stock outperform value stocksMarket Risk Summary & Technical Pattern Alert System - DonanımHaber
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Procept BioRobotics price target lowered to $47 from $50 at Truist - TipRanks
Truist Financial Has Lowered Expectations for PROCEPT BioRobotics (NASDAQ:PRCT) Stock Price - MarketBeat
Truist Financial Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Cuts Target Price to $47 - 富途牛牛
Truist Securities Adjusts Price Target on PROCEPT BioRobotics to $47 From $50, Maintains Buy Rating - marketscreener.com
Procept BioRobotics initiated with a buy at UBS - MSN
PROCEPT BioRobotics (PRCT) Stock Analysis: Eyeing a 41% Upside with Robust Revenue Growth - DirectorsTalk Interviews
3 Underrated Robotics Stocks Poised for Huge Gains - Investing.com
PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Shareholders Might Be Looking For Exit - 富途牛牛
Squarepoint Ops LLC Decreases Stake in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Downgraded by Wall Street Zen to Sell - MarketBeat
PROCEPT BioRobotics Corporation $PRCT Shares Bought by Eventide Asset Management LLC - MarketBeat
Bellevue Group AG Acquires 74,355 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
UBS Initiates Coverage of PROCEPT BioRobotics (PRCT) with Buy Recommendation - Nasdaq
UBS initiates Procept BioRobotics stock with Buy rating on utilization growth - Investing.com Australia
PRCT FinancialsIncome Statement - Quiver Quantitative
Procept BioRobotics initiated with a Buy at UBS - TipRanks
UBS Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Raises Target Price to $62 - 富途牛牛
Promising Growth and Investment Opportunity for PROCEPT BioRobotics: Analyst Buy Rating - TipRanks
Frontier Capital Management Co. LLC Acquires 203,602 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
UBS initiates Procept BioRobotics stock with Buy rating on utilization growth By Investing.com - Investing.com South Africa
PROCEPT BioRobotics (PRCT): Reassessing Valuation After BofA Downgrade and Slower Aquablation Growth Concerns - simplywall.st
Axa S.A. Purchases 63,519 Shares of PROCEPT BioRobotics Corporation $PRCT - Defense World
Next Century Growth Investors LLC Buys 62,112 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Federated Hermes Inc. Acquires 25,863 Shares of PROCEPT BioRobotics Corporation $PRCT - Defense World
Does PROCEPT BioRobotics (PRCT) Slower Aquablation Uptake Recast Its Long-Term Market Penetration Story? - Yahoo Finance
Does Slower Aquablation Growth at PROCEPT (PRCT) Hint At A Transition In Its Long-Term Story? - Sahm
PROCEPT BioRobotics Faces Slower Growth As BofA Lowers Rating - Finimize
PROCEPT BioRobotics’ (PRCT) “Neutral” Rating Reaffirmed at Bank of America - Defense World
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Gap DownHere's Why - MarketBeat
PROCEPT BioRobotics has Large Market Opportunity, but Utilization Growth has Slowed, BofA Says - marketscreener.com
Procept Biorobotics Shares Slide Amid Downgrade - TipRanks
Procept BioRobotics downgraded to neutral at BofA on slowing utilization - MSN
PROCEPT BioRobotics (NASDAQ:PRCT) Given "Neutral" Rating at Bank of America - MarketBeat
Procept BioRobotics stock downgraded by BofA on slowing growth - Investing.com Australia
PROCEPT BioRobotics Corporation $PRCT Shares Acquired by Thematics Asset Management - MarketBeat
PRCT Downgraded by B of A Securities, Price Target Slashed to $3 - GuruFocus
Wall Street Zen Upgrades PROCEPT BioRobotics (NASDAQ:PRCT) to Hold - MarketBeat
Procept Biorobotics Corp Azioni (PRCT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.20%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):